InvestorsHub Logo
Followers 14
Posts 608
Boards Moderated 0
Alias Born 06/05/2015

Re: Robert C Jonson post# 225253

Saturday, 07/04/2015 5:24:02 PM

Saturday, July 04, 2015 5:24:02 PM

Post# of 345786
Robert,
Phase 2, all patients had previously treated Stage IIIb or IV non-squamous NSCLC. Phase 3 study states the same,
"SUNRISE: A Phase III, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial of Bavituximab Plus Docetaxel Versus Docetaxel Alone in Patients With Previously Treated Stage IIIb/IV Non-Squamous Non Small-Cell Lung Cancer"

Am I missing something?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News